Cognition Therapeutics Inc (CGTX NASDAQ) stock market data APIs
$1.4846
0.13(8.8%)
as of September 17, 2025
Try our APIs with
free plan!
Cognition Therapeutics Inc Financial Data Overview
Price chart is built with
Anychart
Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, an orally delivered molecule modulator designed to penetrate the blood-brain barrier and bind selectively to the S2R complex, which is in Phase 2 clinical trial for the treatment of Alzheimer's disease, as well as geographic atrophy secondary to dry age-related macular degeneration and synucleinopathies, such as dementia with Lewy bodies. Cognition Therapeutics, Inc. was incorporated in 2007 and is based in Purchase, New York.
Prev. Close
1.4846
Open
1.6128
High
1.6655
Low
1.4411
52 wk Range
0.2223-3.83
Market Cap
142 M
Shares Outstanding
88 224 K
EPS
-0.11
Beta
1.332
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Cognition Therapeutics Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Cognition Therapeutics Inc data using free add-ons & libraries
Get Cognition Therapeutics Inc Fundamental Data
Cognition Therapeutics Inc Fundamental data includes:
- Net Revenue:
- EBITDA: -52 878 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-12
- EPS/Forecast: -0.11
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Cognition Therapeutics Inc News
New
CGTX, RVPH, SHOT, SONN, AKTX Rally After-Hours On Clinical Updates And Fed Rate Cut Momentum
(RTTNews) - Biotech and healthcare stocks continue to respond sharply to progress in clinical trials, regulatory developments, and broader economic indicators. With the Federal Reserve initiating its ...
Biotechs Rally After Hours On Trial Progress, Funding Moves, And Upcoming Milestones
(RTTNews) - Several biotech names posted notable after-hours gains on Tuesday, driven by clinical trial updates, fresh funding announcements, and upcoming product showcases. From gene editing breakthr...
Here are the top movers in Monday's session.
Here are the top movers in Monday's session, showcasing the stocks with significant price changes. [topmovers] GAINERS TICKER CHANGE COMMENT ATCH [https://www.chartmill.com/stock/quote/A...
Monday Sector Laggards: General Contractors & Builders, Drugs
In trading on Monday, general contractors & builders shares were relative laggards, down on the day by about 1.8%. Helping drag down the group were shares of Horton Inc (DHI), off about 3.9% and shar...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
